SXTC · China SXT Pharmaceuticals, Inc.
$0.05
-0.01 (-15.58%)
At close · Aug 7
Market Cap
$1.74M
Shares
38.22M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.05
Open$0.05
Day$0.04–0.05
52W$0.04–1,047.00
Avg vol 30d78.7M
Short int23K · 0.1% float · 1.0d
Short vol29%
DataJan 2020–Aug 2026
Up next
FQ2-27 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.57
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−100%
below
Price vs 50-day avg
−97%
below
RSI (14)
22
oversold
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−98%
trailing
6-month return
−98%
trailing
YTD return
−100%
this year
Relative strength
−112%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $62 — 200d above 50d
Institutional flow
Flat
1 of 4 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.06% of float · ▼ -50.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
4 holders — mid 3-yr range
Squeeze score
7
low risk · 0–100
Fundamentals
Revenue growth
−2%
Y/Y
Gross margin
13%
contracting
EPS growth
+97%
Y/Y
Free cash flow
$-4.0M
Balance sheet
$27.5M
net cash
Quant / Vol
risk profile
Volatility
223%
annualized · 1-yr
Max drawdown
−100%
past year
ATR
484.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−100%
Bearish
Price vs 50-day avg
−97%
Bearish
RSI (14)
22
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $2 › 200d $62 — 200d above 50d
Institutional flow
Flat
1 of 4 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.06% of float · ▼ -50.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
4 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $0
Now $0 · 0%
52-wk high $1,047
vs 200-day avg -100%
vs 50-day avg -97%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SXTC
this stock
China SXT Pharmaceuticals, Inc.
|
$1.74M | -100.0% | -2.2% | — | 0.1% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$54.35B | +11.9% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$51.17B | +8.6% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$44.17B | +0.5% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Holders
4
- % held
- 0.0%
- Reported
- 1 of 4
- Top holder
- SABBY MANAGEMENT, LLC
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SXTC | -26.6% | -98.2% | -98.3% | -26.6% | -100.0% |
| SPY | +3.5% | +2.4% | +13.4% | +3.5% | +13.4% |
| vs SPY | -30.1% | -100.7% | -111.7% | -30.1% | -113.4% |
Key facts
CIK
1723980
CUSIP
G2161P165
13F (30d)
1 filings
1 filers